Task force IV: pharmacologic interventions. Emergency cardiac care.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004632:Emergency Medical Services; D006331:Heart Diseases / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000701:Analgesics, Opioid; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D002317:Cardiovascular Agents; D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D009599:Nitroprusside; D001285:Atropine; D006493:Heparin; D008012:Lidocaine